PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116126
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116126
According to Mordor Intelligence, the disposable medical supplies market size was valued at USD 0.60 trillion in 2025 and estimated to grow from USD 0.68 trillion in 2026 to reach USD 1.28 trillion by 2031, at a CAGR of 13.52% during the forecast period (2026-2031).

This report is Segmented by Product Type (Gloves, Drapes, Gowns, Masks, Respirators, Needles, Syringes, Procedure Kits, and Trays, and More), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Home-Healthcare Settings, and More), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Healthcare organizations have locked in post-pandemic protocols that prioritize disposable supplies to curb cross-contamination. The Joint Commission cut 70% of process checks but tightened surface-cleaning outcomes, driving hospitals to replace reusable items with single-use equivalents.The shift now extends to general wards where disposable gowns, drapes, and diagnostics are routine. Budget holders factor avoidance of sterilization downtime and litigation costs when justifying higher per-unit spending. Compliance scores tied to patient satisfaction further anchor demand for disposables across the disposable medical supplies market.
Ambulatory surgery centers continue to gain payer support for orthopedics and cardiology procedures. Lean staffing and rapid case turnover require pre-sterile kits that eliminate reprocessing delays. ASCs typically lack in-house sterilizers, so disposable kits speed room turnover and minimize overhead. Reimbursement shifts that incentivize outpatient care strengthen volume, boosting specialized packs containing drapes, catheters, and single-use instruments. The disposable medical supplies market gains a lasting tailwind as ASC footprints widen across OECD nations.
The EU Packaging and Packaging Waste Regulation mandates recyclability by 2030 and shifts disposal fees to producers from August 2026. Healthcare already generates nearly 6 million tons of waste annually, of which fewer than 1% of plastics are recycled.Manufacturers of traditional PVC gloves face rising levies that erode margins. Providers add waste charges into purchasing decisions, tempering the adoption of non-sustainable disposables in cost-sensitive segments of the disposable medical supplies market.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
The gloves segment generated 28.85% of the disposable medical supplies market revenue in 2025 and remains central to everyday clinical routines. Usage frequency rose sharply after COVID-19, and elevated volumes have normalized at higher baselines. Biodegradable gloves are scaling quickly, registering an 11.52% CAGR that outpaces all other sub-categories. Their momentum reflects imminent EPR fees on traditional nitrile and latex waste. Procedure kits and trays also benefit from ambulatory surgery center growth, as pre-pack builds streamline room turnover. Drapes and gowns ride the same efficiency trend, whereas masks and respirators, though moderating from pandemic peaks, still post healthy demand given occupational safety standards. Needles and syringes post stable gains, tied to chronic-care injections migrating into homes. Catheter makers face PTFE supply constraints, prompting capacity investments and alternative materials development.
Innovators are advancing nanofiber wound dressings and connected single-use sensors that report data to electronic records, broadening the category. Evonik's RESOMER polymer platform illustrates how material science responds to dual performance and sustainability targets. As more hospitals link purchasing to waste disclosure, bio-based lines gain shelf space. Consequently, the disposable medical supplies market size for biodegradable gloves is projected to log visible share gains by 2031.
North America retained a 37.05% share of the disposable medical supplies market in 2025, thanks to strict infection-control oversight and fresh capital investments in local manufacturing. Tariffs that climb to 100% on certain Chinese gloves by 2026 spur companies such as Kimberly-Clark to pump USD 2 billion into Ohio and South Carolina plants, creating more than 900 skilled roles. Group Purchasing Organizations standardize specifications, accelerating product turnover and ensuring steady volume across the network.
Europe remains committed to sustainable healthcare procurement. EPR legislation that compels recyclable packaging by 2030 has amplified interest in bio-polymer disposable lines. Hospitals in Germany and the Nordics publish annual waste metrics, and suppliers able to lower disposal fees gain bidding advantages. While the continent's population growth is muted, aging demographics sustain procedural volumes and drive continuous demand within the disposable medical supplies market.
Asia Pacific is expected to chart a 7.62% CAGR up to 2031, the fastest among all regions. Urbanization and rising healthcare funding expand bed capacity across China, India, Indonesia, and Vietnam. Although trade tensions redirect some export orders away from China, regional manufacturers in Malaysia and Thailand seize glove contracts to backfill U.S. demand. Meanwhile, emerging private hospitals in India adopt Western infection-control norms, boosting average per-patient disposable consumption.
Middle East and Africa, along with South America, contribute modest but rising demand as governments invest in hospital infrastructure and seek to reduce healthcare-acquired infections. Multilateral funding programs often include clauses for single-use kits to meet global accreditation benchmarks. Collectively, these developing territories add incremental volume and diversify revenue streams for suppliers active in the disposable medical supplies market.